Mark Lawler

Chair, The Lancet Oncology Commission

About Mark Lawler

Mark Lawler is Professor of Digital Health at Queen’s University Belfast and led the Lancet Oncology European Groundshot Commission. He is a member of the board of the European Cancer Organisation, Europe’s largest multi-professional cancer organisation) and co-chairs their Special Focussed Network on the Impact of COVID-19 on Cancer and is a member of the Scientific Committee of the European Cancer Patient Coalition (Europe’s largest cancer patient advocacy organisation).

Stakeholder Group

Academia NGO/Civil Society

Intro Content

COVID-19 Recovery Health Innovation

Follow the Science, Follow the Data: Averting a European cancer crisis

The COVID-19 pandemic, the war in Ukraine and the cost-of-living crisis have unravelled our progress on cancer survival, but we also have a significant opportunity. The ambitious but achievable goal? An average of 70% ten-year survival rates for all European patients with cancer by 2035. Banner: Shutterstock/Rapeepat Pornsipak

Influencer Of